Barclays lowered the firm’s price target on Marsh McLennan (MRSH) to $206 from $209 and keeps an Overweight rating on the shares. The firm adjusted targets in the insurance group as part of a Q1 preview. Premium growth and broker organic growth “are likely to remain sluggish,” the analyst tells investors in a research note. However, Barclays sees solid margins and strong capital deployment still contributing to reported book value growth in Q1.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRSH:
- Marsh McLennan Agency acquires Seitz Insurance Agency, terms not disclosed
- Marsh McLennan price target lowered to $200 from $206 at Keefe Bruyette
- Ex-Dividend Date Nearing for These 10 Stocks – Week of April 6, 2026
- Marsh McLennan price target lowered to $190 from $195 at Morgan Stanley
- Marsh names Ted Moynihan CEO of Marsh Management Consulting, Oliver Wyman